ACVR2A Facilitates Trophoblast Cell Invasion through TCF7/c-JUN Pathway in Pre-eclampsia Progression

Shujing Yang,Huanyao Liu,Jieshi Hu,Binjun Chen,Wanlu An,Xuwen Song,Yi Yang,Fang He

DOI: https://doi.org/10.1101/2024.09.03.24312808

2024-09-04

Abstract:Pre-eclampsia (PE) is a serious pregnancy disorder linked to genetic factors, particularly the ACVR2A gene, which encodes a receptor involved in the activin signaling pathway and plays a critical role in reproductive processes. Transcriptomic data analysis and experimental verification confirmed a downregulation of ACVR2A expression in placental tissues from PE patients. In this study, CRISPR/Cas9 technology was employed to investigate the effect of ACVR2A gene deletion on trophoblast cells using the HTR8/SVneo and JAR cell lines.. Deletion of ACVR2A inhibits trophoblastic migration, proliferation, and invasion, underscoring its pivotal role in cellular function. RNA-seq data analysis unveiled an intricate regulatory network influenced by ACVR2A gene knockout, especially in the TCF7/c-JUN pathway. By employing RT-PCR and immunohistochemical analysis, a potential association between ACVR2A and the TCF7/c-JUN pathway was hypothesized and confirmed. The complexity of PE onset and the significance of genetic factors were emphasized, particularly the role of the ACVR2A gene identified in GWAS. This study established a robust foundation for delving deeper into the intricate mechanisms of PE, paving the way for focused early intervention, personalized treatment, and enhanced obstetric healthcare.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role and mechanism of the ACVR2A gene in the progression of pre - eclampsia (PE). Specifically, through analyzing transcriptome data and experimental verification, the researchers found that the expression of the ACVR2A gene was down - regulated in the placental tissues of PE patients. In order to further explore the function of the ACVR2A gene, the researchers used the CRISPR/Cas9 technology to knock out the ACVR2A gene in the HTR8/SVneo and JAR cell lines and observed the changes in the migration, proliferation and invasion abilities of these cells. The research results showed that the deletion of the ACVR2A gene inhibited the migration, proliferation and invasion of trophoblast cells, highlighting its crucial role in cell functions. In addition, through RNA - seq data analysis, the researchers revealed the complex regulatory network after the knockout of the ACVR2A gene, especially the changes in the TCF7/c - JUN pathway. Through RT - PCR and immunohistochemical analysis, the researchers hypothesized and confirmed the potential association between the ACVR2A gene and the TCF7/c - JUN pathway. This finding emphasizes the complexity of the pathogenesis of PE and the importance of genetic factors, especially the role of the ACVR2A gene identified in genome - wide association studies (GWAS). In conclusion, this paper aims to deeply explore the specific mechanism of the ACVR2A gene in the pathogenesis of PE, providing a theoretical basis for early intervention, personalized treatment and improvement of obstetric healthcare.

ACVR2A Facilitates Trophoblast Cell Invasion through TCF7/c-JUN Pathway in Pre-eclampsia Progression

Upregulated LncZBTB39 in Pre-Eclampsia and Its Effects on Trophoblast Invasion and Migration Via Antagonizing the Inhibition of Mir-210 on THSD7A Expression.

AC092100.1 promotes angiogenesis in pre-eclampsia through YTHDC2/VEGFA signaling

Increased LINC00922 in preeclampsia regulates the proliferation, invasion, and migration of placental trophoblast cells

Declined placental PLAC1 expression is involved in preeclampsia.

Dissecting human trophoblast cell transcriptional heterogeneity in preeclampsia using single‐cell RNA sequencing

Down-regulation of PCBP2 Suppresses the Invasion and Migration of Trophoblasts via the WNT5A/ROR2 Pathway in Preeclampsia

Extracellular vesicle‐derived microRNA‐18b ameliorates preeclampsia by enhancing trophoblast proliferation and migration via Notch2/TIM3/mTORC1 axis

Down-Regulated JDP2 Attenuated Trophoblast Invasion and Migration in Preeclampsia by Inhibiting Epithelial-Mesenchymal Transition through the Wnt/β-Catenin Pathway

Down‐regulation of Endothelial Protein C Receptor Promotes Preeclampsia by Affecting Actin Polymerization

TET3-mediated novel regulatory mechanism affecting trophoblast invasion and migration: Implications for preeclampsia development

Resveratrol promotes trophoblast invasion in pre‐eclampsia by inducing epithelial‐mesenchymal transition

MiR-95-3p/EPM2A/MMP2 Contributes to the Pathogenesis of Severe Preeclampsia Through the Regulation of Trophoblast Biological Behaviour

miR-215-5p decreases migration and invasion of trophoblast cells through regulating CDC6 in preeclampsia

NR2F1 overexpression alleviates trophoblast cell dysfunction by inhibiting GDF15/MAPK axis in preeclampsia

Hypoxia-induced Downregulation of SRC-3 Suppresses Trophoblastic Invasion and Migration Through Inhibition of the AKT/mTOR Pathway: Implications for the Pathogenesis of Preeclampsia

LncRNA Uc003fir Promotes CCL5 Expression and Negatively Affects Proliferation and Migration of Trophoblast Cells in Preeclampsia.

Trophoblast-Derived Extracellular Vesicles Promote Preeclampsia by Regulating Macrophage Polarization

The Role of Junctional Adhesion Molecule-C in Trophoblast Differentiation and Function During Normal Pregnancy and Preeclampsia

HOXB3 promotes trophoblast cell proliferation, invasion, and migration to alleviate preeclampsia via mediating the Notch/Wnt/β-catenin pathway

TAGLN2-Regulated Trophoblast Migration, Invasion and Fusion are Impaired in Preeclampsia